Walleye Capital’s Japer Therapeutics Warrants JSPRW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | – | Sell |
-200,000
| Closed | -$2.7K | – | 6074 |
|
|
2026
Q2 | $2.7K | Hold |
200,000
| – | – | ﹤0.01% | 4576 |
|
|
2026
Q1 | $4.38K | Hold |
200,000
| – | – | ﹤0.01% | 4207 |
|
|
2025
Q4 | $8.02K | Sell |
200,000
-360,061
| -64% | -$40.6K | ﹤0.01% | 4309 |
|
|
2025
Q3 | $44.6K | Hold |
560,061
| – | – | ﹤0.01% | 4037 |
|
|
2025
Q2 | $70K | Hold |
560,061
| – | – | ﹤0.01% | 3925 |
|
|
2025
Q1 | $80.1K | Sell |
560,061
-13,579
| -2% | -$2.14K | ﹤0.01% | 3700 |
|
|
2024
Q4 | $120K | Sell |
573,640
-22,374
| -4% | -$4.7K | ﹤0.01% | 4049 |
|
|
2024
Q3 | $119K | Hold |
596,014
| – | – | ﹤0.01% | 4320 |
|
|
2024
Q2 | $119K | Hold |
596,014
| – | – | ﹤0.01% | 4634 |
|
|
2024
Q1 | $108K | Sell |
596,014
-99,000
| -14% | -$15.7K | ﹤0.01% | 4352 |
|
|
2023
Q4 | $55.6K | Sell |
695,014
-5,422
| -0.8% | -$450 | ﹤0.01% | 4268 |
|
|
2023
Q3 | $35K | Sell |
700,436
-301
| -0% | -$26 | ﹤0.01% | 4277 |
|
|
2023
Q2 | $98.2K | Buy |
700,737
+45,903
| +7% | +$7.07K | ﹤0.01% | 3444 |
|
|
2023
Q1 | $131K | Buy |
654,834
+629,775
| +2,513% | +$91.9K | ﹤0.01% | 2780 |
|
|
2022
Q4 | $752 | Hold |
25,059
| – | – | ﹤0.01% | 3072 |
|
|
2022
Q3 | $2K | Hold |
25,059
| – | – | ﹤0.01% | 3060 |
|
|
2022
Q2 | $2K | Hold |
25,059
| – | – | ﹤0.01% | 2249 |
|
|
2022
Q1 | $7K | Hold |
25,059
| – | – | ﹤0.01% | 2155 |
|
|
2021
Q4 | $37K | Sell |
25,059
-55,625
| -69% | -$77.5K | ﹤0.01% | 1817 |
|
|
2021
Q3 | $119K | Buy |
+80,684
| New | +$86.3K | ﹤0.01% | 1294 |
|
|
2021
Q1 | – | Sell |
-33,410
| Closed | -$48K | – | 1258 |
|
|
2020
Q4 | $48K | Sell |
33,410
-17,790
| -35% | -$22.3K | ﹤0.01% | 874 |
|
|
2020
Q3 | $57K | Buy |
+51,200
| New | +$51.8K | 0.01% | 751 |
|
Walleye Capital's JSPRW Position: Q3 2026 in Review
Walleye Capital sold out of Japer Therapeutics Warrants (JSPRW) in Q3 2026, closing a stake of 200,000 shares — an estimated $2.7K sold.
Walleye Capital first reported a position in JSPRW in Q3 2020 and held it in 22 quarters. The position peaked at $131K in Q1 2023. 1 fund tracked by Wall St. Rank holds JSPRW as of Q3 2026.
- Walleye Capital reported no remaining Japer Therapeutics Warrants position as of Q3 2026 after selling out during the quarter.
- Walleye Capital sold 200,000 Japer Therapeutics Warrants shares in Q3 2026, an estimated $2.7K.
- Walleye Capital first reported a position in Japer Therapeutics Warrants in Q3 2020 and held it in 22 quarters.
- Walleye Capital's Japer Therapeutics Warrants position peaked at $131K in Q1 2023.
- 1 fund tracked by Wall St. Rank held Japer Therapeutics Warrants as of Q3 2026.
Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.